ATE361755T1 - Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen - Google Patents
Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungenInfo
- Publication number
- ATE361755T1 ATE361755T1 AT01973674T AT01973674T ATE361755T1 AT E361755 T1 ATE361755 T1 AT E361755T1 AT 01973674 T AT01973674 T AT 01973674T AT 01973674 T AT01973674 T AT 01973674T AT E361755 T1 ATE361755 T1 AT E361755T1
- Authority
- AT
- Austria
- Prior art keywords
- spinal cord
- cord injury
- regeneration
- thrombomodulin analogs
- thrombomodulin
- Prior art date
Links
- 102000012607 Thrombomodulin Human genes 0.000 title abstract 2
- 108010079274 Thrombomodulin Proteins 0.000 title abstract 2
- 208000020431 spinal cord injury Diseases 0.000 title abstract 2
- 230000008929 regeneration Effects 0.000 title 1
- 238000011069 regeneration method Methods 0.000 title 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/366—Thrombomodulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Communication Cables (AREA)
- Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
- Ropes Or Cables (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22971400P | 2000-08-31 | 2000-08-31 | |
| US09/938,405 US20020111296A1 (en) | 2000-08-31 | 2001-08-23 | Thrombomodulin analogs for use in recovery of spinal cord injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361755T1 true ATE361755T1 (de) | 2007-06-15 |
Family
ID=26923554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01973674T ATE361755T1 (de) | 2000-08-31 | 2001-08-31 | Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20020111296A1 (enExample) |
| EP (1) | EP1365788B1 (enExample) |
| JP (1) | JP2004521076A (enExample) |
| AT (1) | ATE361755T1 (enExample) |
| AU (2) | AU9322901A (enExample) |
| CA (1) | CA2420900A1 (enExample) |
| DE (1) | DE60128399T2 (enExample) |
| DK (1) | DK1365788T3 (enExample) |
| ES (1) | ES2287161T3 (enExample) |
| IL (2) | IL154600A0 (enExample) |
| NO (1) | NO20030919L (enExample) |
| PT (1) | PT1365788E (enExample) |
| WO (1) | WO2002017953A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006005362A1 (en) * | 2004-07-13 | 2006-01-19 | Paion Deutschland Gmbh | Production of mammalian proteins in plant cells |
| US20060148695A1 (en) * | 2005-01-03 | 2006-07-06 | National Cheng Kung University | Novel angiogenic composition and use thereof |
| US8293710B2 (en) * | 2005-01-03 | 2012-10-23 | Blue Blood Biotech Corp. | Method for treating wounds using an EGF-like domain of thrombomodulin |
| EP1912660A1 (en) * | 2005-08-11 | 2008-04-23 | Medigenes Co., Ltd. | Pharmaceutical composition for the treatment of nerve damage comprising blood plasma or serum |
| AR067345A1 (es) * | 2007-07-10 | 2009-10-07 | Paion Deutschland Gmbh | Uso de trombomodulina para la preparacion de un medicamento trombolitico |
| EP2014296A1 (en) * | 2007-07-10 | 2009-01-14 | PAION Deutschland GmbH | Novel strategies for increasing the reperfusion in obstructed blood vessel |
| WO2010006635A1 (en) * | 2008-07-16 | 2010-01-21 | Paion Deutschland Gmbh | Treatment of inflammatory bowel disease |
| EP2320936A1 (en) * | 2008-07-16 | 2011-05-18 | PAION Deutschland GmbH | Prevention and treatment of radiation injury |
| DK2857037T3 (da) | 2012-05-31 | 2019-07-22 | Univ Kinki | Middel til forebyggelse og/eller behandling af perifere neuropatiske smerter forårsaget af anticancerlægemiddel |
| CA3112679A1 (en) | 2018-09-28 | 2020-04-02 | Asahi Kasei Pharma Corporation | Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063763A (en) * | 1989-04-28 | 2000-05-16 | Schering Aktiengesellschaft | Protease-resistant thrombomodulin analogs |
| US5466668A (en) * | 1989-04-28 | 1995-11-14 | Schering Aktiengesellschaft | Superior thrombomodulin analogs for pharmaceutical use |
| US5256770A (en) * | 1990-04-09 | 1993-10-26 | Schering Ag | Oxidation resistant thrombomodulin analogs |
| JP3789147B2 (ja) * | 1995-04-11 | 2006-06-21 | 旭化成ファーマ株式会社 | 脊髄損傷後の神経障害に対する治療剤 |
-
2001
- 2001-08-23 US US09/938,405 patent/US20020111296A1/en not_active Abandoned
- 2001-08-31 AT AT01973674T patent/ATE361755T1/de not_active IP Right Cessation
- 2001-08-31 WO PCT/US2001/041930 patent/WO2002017953A2/en not_active Ceased
- 2001-08-31 ES ES01973674T patent/ES2287161T3/es not_active Expired - Lifetime
- 2001-08-31 AU AU9322901A patent/AU9322901A/xx active Pending
- 2001-08-31 CA CA002420900A patent/CA2420900A1/en not_active Abandoned
- 2001-08-31 DK DK01973674T patent/DK1365788T3/da active
- 2001-08-31 IL IL15460001A patent/IL154600A0/xx active IP Right Grant
- 2001-08-31 AU AU2001293229A patent/AU2001293229B2/en not_active Ceased
- 2001-08-31 EP EP01973674A patent/EP1365788B1/en not_active Expired - Lifetime
- 2001-08-31 DE DE60128399T patent/DE60128399T2/de not_active Expired - Fee Related
- 2001-08-31 JP JP2002522926A patent/JP2004521076A/ja not_active Withdrawn
- 2001-08-31 PT PT01973674T patent/PT1365788E/pt unknown
-
2003
- 2003-02-24 IL IL154600A patent/IL154600A/en not_active IP Right Cessation
- 2003-02-27 NO NO20030919A patent/NO20030919L/no not_active Application Discontinuation
- 2003-04-10 US US10/410,195 patent/US20040002446A1/en not_active Abandoned
-
2008
- 2008-08-22 US US12/197,031 patent/US20090143281A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090143281A1 (en) | 2009-06-04 |
| EP1365788B1 (en) | 2007-05-09 |
| DE60128399D1 (de) | 2007-06-21 |
| HK1062398A1 (en) | 2004-11-05 |
| DE60128399T2 (de) | 2008-01-10 |
| JP2004521076A (ja) | 2004-07-15 |
| US20040002446A1 (en) | 2004-01-01 |
| WO2002017953A3 (en) | 2003-10-09 |
| DK1365788T3 (da) | 2007-09-17 |
| NO20030919D0 (no) | 2003-02-27 |
| CA2420900A1 (en) | 2002-03-07 |
| IL154600A (en) | 2009-02-11 |
| AU2001293229B2 (en) | 2007-04-05 |
| WO2002017953A2 (en) | 2002-03-07 |
| IL154600A0 (en) | 2003-09-17 |
| PT1365788E (pt) | 2007-08-10 |
| EP1365788A2 (en) | 2003-12-03 |
| US20020111296A1 (en) | 2002-08-15 |
| NO20030919L (no) | 2003-04-10 |
| AU9322901A (en) | 2002-03-13 |
| ES2287161T3 (es) | 2007-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
| DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| DE60214477D1 (de) | Implantat zur Regeneration von Knorpelgewebe | |
| ATE401309T1 (de) | Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen | |
| ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
| ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
| ATE452655T1 (de) | Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| DE60128399D1 (de) | Verwendung von thrombomodulinanaloga zur regenerierung von rückenmarkverletzungen | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| DE60214355D1 (de) | Exemestan zur behandlung von hormonabhängigen störungen | |
| DE60223718D1 (de) | Verwendung von norepinephrin wiederaufnahmehemmern zur behandlung von kognitiven störungen | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| ATE402694T1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz | |
| DE60117122D1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
| DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
| ATE267608T1 (de) | Verwendung von fsh zur behandlung von infertilität | |
| DE60217653D1 (de) | Verwendung von melatonin zur behandlung der mit konzentrationsschwäche einhergehenden hyperaktivität | |
| DE50212649D1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| ATE347883T1 (de) | Verwendung von n-(2-aryl-propionyl)-sulfonamiden zur behandlung von rückenmarkverletzungen | |
| ATE267209T1 (de) | Reinigung von carboxaldehyd | |
| DE602004011486D1 (de) | Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1365788 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |